AU649066B2 - Circular extension for generating multiple nucleic acid complements - Google Patents

Circular extension for generating multiple nucleic acid complements Download PDF

Info

Publication number
AU649066B2
AU649066B2 AU84173/91A AU8417391A AU649066B2 AU 649066 B2 AU649066 B2 AU 649066B2 AU 84173/91 A AU84173/91 A AU 84173/91A AU 8417391 A AU8417391 A AU 8417391A AU 649066 B2 AU649066 B2 AU 649066B2
Authority
AU
Australia
Prior art keywords
nucleic acid
single strand
template
circular
linear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU84173/91A
Other languages
English (en)
Other versions
AU8417391A (en
Inventor
David A Driver
Jerry L. Ruth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngene Inc
Original Assignee
Syngene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngene Inc filed Critical Syngene Inc
Publication of AU8417391A publication Critical patent/AU8417391A/en
Application granted granted Critical
Publication of AU649066B2 publication Critical patent/AU649066B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AU84173/91A 1990-07-25 1991-07-17 Circular extension for generating multiple nucleic acid complements Expired - Fee Related AU649066B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55864590A 1990-07-25 1990-07-25
US558645 1990-07-25
PCT/US1991/005067 WO1992001813A1 (en) 1990-07-25 1991-07-17 Circular extension for generating multiple nucleic acid complements

Publications (2)

Publication Number Publication Date
AU8417391A AU8417391A (en) 1992-02-18
AU649066B2 true AU649066B2 (en) 1994-05-12

Family

ID=24230368

Family Applications (1)

Application Number Title Priority Date Filing Date
AU84173/91A Expired - Fee Related AU649066B2 (en) 1990-07-25 1991-07-17 Circular extension for generating multiple nucleic acid complements

Country Status (5)

Country Link
EP (1) EP0542874A4 (de)
JP (1) JPH06500014A (de)
AU (1) AU649066B2 (de)
CA (1) CA2087256A1 (de)
WO (1) WO1992001813A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143495A (en) * 1995-11-21 2000-11-07 Yale University Unimolecular segment amplification and sequencing
US9487823B2 (en) 2002-12-20 2016-11-08 Qiagen Gmbh Nucleic acid amplification

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU648842B2 (en) * 1990-09-21 1994-05-05 Amgen, Inc. Enzymatic synthesis of oligonucleotides
US5645987A (en) * 1990-09-21 1997-07-08 Amgen Inc. Enzymatic synthesis of oligonucleotides
US5683874A (en) * 1991-03-27 1997-11-04 Research Corporation Technologies, Inc. Single-stranded circular oligonucleotides capable of forming a triplex with a target sequence
US6261808B1 (en) 1992-08-04 2001-07-17 Replicon, Inc. Amplification of nucleic acid molecules via circular replicons
US6096880A (en) * 1993-04-15 2000-08-01 University Of Rochester Circular DNA vectors for synthesis of RNA and DNA
US6077668A (en) * 1993-04-15 2000-06-20 University Of Rochester Highly sensitive multimeric nucleic acid probes
US7135312B2 (en) 1993-04-15 2006-11-14 University Of Rochester Circular DNA vectors for synthesis of RNA and DNA
US5648211A (en) * 1994-04-18 1997-07-15 Becton, Dickinson And Company Strand displacement amplification using thermophilic enzymes
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
WO1997020948A1 (en) 1995-12-05 1997-06-12 Koch Joern Erland A cascade nucleic acid amplification reaction
GB9609213D0 (en) * 1996-05-02 1996-07-03 Tepnel Medical Ltd Amplification of nucleic acids
JP3415995B2 (ja) * 1996-06-10 2003-06-09 科学技術振興事業団 高分子マイクロ遺伝子重合体の作成方法
GB9626074D0 (en) * 1996-12-16 1997-02-05 Cytocell Ltd Nucleic acids amplification assay
EP1985714B1 (de) * 1998-03-25 2012-02-29 Olink AB Zwei Affinitätsproben und Rolling-Circle-Replikation zur Detektion eines Zielmoleküls verwendende Verfahren und Kit
US6316229B1 (en) 1998-07-20 2001-11-13 Yale University Single molecule analysis target-mediated ligation of bipartite primers
US6287824B1 (en) 1998-09-15 2001-09-11 Yale University Molecular cloning using rolling circle amplification
JP2002525078A (ja) * 1998-09-15 2002-08-13 イェール ユニバーシティ 人工的長末端反復配列
EP1121469A2 (de) * 1998-10-12 2001-08-08 Attomol GmbH Molekulare Diagnostika Verfahren und kit zum direkten nachweis von nukleotidsequenzen, aminosäuresequenzen oder antigenen
GB9822777D0 (en) * 1998-10-20 1998-12-16 Tepnel Medical Ltd Template chain reaction
US6830884B1 (en) 1998-12-15 2004-12-14 Molecular Staging Inc. Method of amplification
US20020025519A1 (en) 1999-06-17 2002-02-28 David J. Wright Methods and oligonucleotides for detecting nucleic acid sequence variations
CA2387576C (en) 1999-10-18 2011-05-10 Prince Henry's Institute Of Medical Research Immuno-interactive fragments of the .alpha.c subunit of inhibin
JP2003532380A (ja) * 1999-12-02 2003-11-05 モレキュラー ステージング,インコーポレイテッド 線状自己アニーリングセグメントからの一本鎖環状dnaの産出
US7947291B2 (en) 2000-01-25 2011-05-24 The University Of Queensland Modified surface antigen
US6221603B1 (en) * 2000-02-04 2001-04-24 Molecular Dynamics, Inc. Rolling circle amplification assay for nucleic acid analysis
AU2001238106A1 (en) * 2000-02-10 2001-08-20 The Penn State Research Foundation Method for amplifying full length single strand polynucleotide sequences
US6291187B1 (en) * 2000-05-12 2001-09-18 Molecular Staging, Inc. Poly-primed amplification of nucleic acid sequences
US6323009B1 (en) 2000-06-28 2001-11-27 Molecular Staging, Inc. Multiply-primed amplification of nucleic acid sequences
AU2001271722B2 (en) 2000-06-30 2006-04-13 Qiagen, Gmbh Signal amplification with lollipop probes
US6312913B1 (en) * 2000-07-21 2001-11-06 Incyte Genomics, Inc. Method for isolating and characterizing nucleic acid sequences
AUPR030900A0 (en) 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex
US6573051B2 (en) 2001-03-09 2003-06-03 Molecular Staging, Inc. Open circle probes with intramolecular stem structures
AUPR446701A0 (en) 2001-04-18 2001-05-17 Gene Stream Pty Ltd Transgenic mammals for pharmacological and toxicological studies
US7838270B2 (en) 2001-05-22 2010-11-23 The University Of Chicago Target-dependent transcription using deletion mutants of N4 RNA polymerase
GB2378245A (en) * 2001-08-03 2003-02-05 Mats Nilsson Nucleic acid amplification method
JP2005535629A (ja) 2002-06-27 2005-11-24 ザ ユニバーシティ オブ クイーンズランド 分化調節薬剤およびその使用法
WO2011063477A1 (en) 2009-11-30 2011-06-03 Queensland University Of Technology Fibronectin: growth factor chimeras
AU2003900481A0 (en) 2003-02-05 2003-02-20 Queensland University Of Technology Synthetic modulators of cell migration and growth
US20100143442A1 (en) 2003-02-05 2010-06-10 Queensland University Of Technology Growth factor complexes and modulation of cell migration and growth
US8043834B2 (en) 2003-03-31 2011-10-25 Qiagen Gmbh Universal reagents for rolling circle amplification and methods of use
AU2003902253A0 (en) 2003-05-12 2003-05-29 The University Of Queensland Method for increasing product yield
WO2005108608A1 (en) * 2004-05-10 2005-11-17 Kabushiki Kaisha Dnaform Method for isolating nucleic acid isoforms
CA2591659A1 (en) 2004-12-17 2006-06-22 Monash University Regulation of metalloprotease cleavage of cell surface proteins
EP1833994A4 (de) * 2005-01-04 2009-09-02 Hitachi Chemical Co Ltd Rolling-circle-verstärkung einer primer-erzeugung
GB0504774D0 (en) * 2005-03-08 2005-04-13 Lingvitae As Method
EP1863908B1 (de) 2005-04-01 2010-11-17 Qiagen GmbH Reverse transkription und amplifikation von rna bei simultaner degradierung von dna
EP1871896B1 (de) 2005-04-12 2015-06-03 Olink AB Zirkulare Sonden und deren Verwendung zur Identifizierung von Biomolekülen
WO2006108423A2 (en) 2005-04-12 2006-10-19 In Situ Rcp A/S Under Founding Methods for production of oligonucleotides
DK1907583T4 (da) 2005-06-15 2020-01-27 Complete Genomics Inc Enkeltmolekyle-arrays til genetisk og kemisk analyse
EP1762627A1 (de) 2005-09-09 2007-03-14 Qiagen GmbH Verfahren zur Aktivierung einer Nukleinsäure für eine Polymerase-Reaktion
CA2624324A1 (en) 2005-10-06 2007-04-19 Lucigen Corporation Thermostable viral polymerases and methods of use
US7960104B2 (en) * 2005-10-07 2011-06-14 Callida Genomics, Inc. Self-assembled single molecule arrays and uses thereof
SG10201405158QA (en) * 2006-02-24 2014-10-30 Callida Genomics Inc High throughput genome sequencing on dna arrays
US7501254B2 (en) 2006-07-20 2009-03-10 Ghc Technologies, Inc. Methods and compositions for amplification and capture of nucleic acid sequences
EP2058396A4 (de) * 2006-08-31 2010-06-30 Toyo Seikan Kaisha Ltd Nukleinsäureamplifikationsverfahren
WO2008070352A2 (en) 2006-10-27 2008-06-12 Complete Genomics, Inc. Efficient arrays of amplified polynucleotides
US20100203051A1 (en) 2007-05-31 2010-08-12 The University Of Queensland Diagnostic markers for ankylosing spondylitis and uses thereof
GB0901593D0 (en) 2009-01-30 2009-03-11 Touchlight Genetics Ltd Production of closed linear DNA
GB201013153D0 (en) 2010-08-04 2010-09-22 Touchlight Genetics Ltd Primer for production of closed linear DNA
EP3578205A1 (de) 2010-08-06 2019-12-11 ModernaTX, Inc. Pharmazeutische zusammensetzungen enthaltenbearbeitete nukleinsäuren und ihre medizinische verwendung
HUE058896T2 (hu) 2010-10-01 2022-09-28 Modernatx Inc N1-metil-pszeudo-uracilt tartalmazó ribonukleinsavak és azok felhasználásai
JP2014511687A (ja) 2011-03-31 2014-05-19 モデルナ セラピューティクス インコーポレイテッド 工学操作された核酸の送達および製剤
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
RU2648950C2 (ru) 2011-10-03 2018-04-02 Модерна Терапьютикс, Инк. Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
EP2791160B1 (de) 2011-12-16 2022-03-02 ModernaTX, Inc. Modifizierte mrna zusammensetzungen
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9254311B2 (en) 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
AU2013243951A1 (en) 2012-04-02 2014-10-30 Moderna Therapeutics, Inc. Modified polynucleotides for the production of secreted proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
EP2920324B1 (de) 2012-11-14 2017-12-27 Olink Bioscience AB Lokalisiertes rca-basiertes verstärkungsverfahren
EP2922554B1 (de) 2012-11-26 2022-02-23 ModernaTX, Inc. Terminal modifizierte rns
EP3587592A1 (de) * 2013-03-15 2020-01-01 Theranos IP Company, LLC Nukleinsäureamplifikation
WO2014145298A1 (en) 2013-03-15 2014-09-18 Theranos, Inc. Nucleic acid amplification
US10450595B2 (en) 2013-03-15 2019-10-22 Theranos Ip Company, Llc Nucleic acid amplification
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
EP2971123B1 (de) 2013-03-15 2021-05-05 Labrador Diagnostics LLC Nukleinsäureamplifikation
WO2015034925A1 (en) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Circular polynucleotides
EP3042208A4 (de) 2013-09-06 2017-04-19 Theranos, Inc. Systeme und verfahren zur erkennung von infektionskrankheiten
WO2015048744A2 (en) 2013-09-30 2015-04-02 Moderna Therapeutics, Inc. Polynucleotides encoding immune modulating polypeptides
EA201690675A1 (ru) 2013-10-03 2016-08-31 Модерна Терапьютикс, Инк. Полинуклеотиды, кодирующие рецептор липопротеинов низкой плотности
GB201321123D0 (en) 2013-11-29 2014-01-15 Linea Ab Q Amplification of circular molecules
EP3256591A4 (de) 2015-02-13 2018-08-08 Translate Bio Ma, Inc. Hybride oligonukleotide und verwendungen davon
US20170151281A1 (en) 2015-02-19 2017-06-01 Batu Biologics, Inc. Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancer
DE112016003948T5 (de) 2015-08-31 2018-05-09 City Of Sapporo Molekulare verfahren zum beurteilen einer urothelialen erkrankung
GB201614023D0 (en) 2016-08-16 2016-09-28 Olink Bioscience Ab Double-stranded circle probes
EP3558355A2 (de) 2016-12-23 2019-10-30 CureVac AG Henipavirus-impfstoff
WO2018115527A2 (en) 2016-12-23 2018-06-28 Curevac Ag Mers coronavirus vaccine
EP3558354A1 (de) 2016-12-23 2019-10-30 CureVac AG Impfstoff gegen das lassa-virus
CA3050614A1 (en) 2017-03-17 2018-09-20 Curevac Ag Rna vaccine and immune checkpoint inhibitors for combined anticancer therapy
WO2018209398A1 (en) 2017-05-17 2018-11-22 Microbio Pty Ltd Biomarkers and uses thereof
CN111328287A (zh) 2017-07-04 2020-06-23 库瑞瓦格股份公司 新型核酸分子
US20200306286A1 (en) 2017-12-15 2020-10-01 Flagship Pioneering Innovations Vi, Llc Compositions comprising circular polyribonucleotides and uses thereof
EP3773702A2 (de) 2018-04-05 2021-02-17 CureVac AG Neue gelbfieber-nukleinsäuremoleküle zur impfung
CN112292395A (zh) 2018-04-17 2021-01-29 库瑞瓦格股份公司 用于疫苗接种的新型rsv rna分子和组合物
EP3813874A1 (de) 2018-06-27 2021-05-05 CureVac AG Neuartige lassa-virus-rna-moleküle und zusammensetzungen zur impfung
AU2019410737A1 (en) 2018-12-21 2021-06-10 CureVac SE RNA for malaria vaccines
WO2020161342A1 (en) 2019-02-08 2020-08-13 Curevac Ag Coding rna administered into the suprachoroidal space in the treatment of ophtalmic diseases
ES2928724T3 (es) 2019-03-01 2022-11-22 Flagship Pioneering Innovations Vi Llc Polirribonucleótidos y usos cosméticos de los mismos
EP3930683A1 (de) 2019-03-01 2022-01-05 Flagship Pioneering Innovations VI, LLC Zusammensetzungen, verfahren und kits zur verabreichung von polyribonukleotiden
CA3128626A1 (en) 2019-03-04 2020-09-10 Flagship Pioneering Innovations Vi, Llc Circular polyribonucleotides and pharmaceutical compositions thereof
CN113661242A (zh) 2019-03-25 2021-11-16 旗舰创业创新第六有限责任公司 包含经修饰的环状多核糖核苷酸的组合物及其用途
AU2020292427A1 (en) 2019-06-14 2022-01-06 Flagship Pioneering Innovations Vi, Llc Circular RNAs for cellular therapy
AU2020296190A1 (en) 2019-06-19 2022-01-06 Flagship Pioneering Innovations Vi, Llc Methods of dosing circular polyribonucleotides
EP3986469A1 (de) 2019-06-19 2022-04-27 Flagship Pioneering Innovations VI, LLC Zusammensetzungen mit kreisförmigen polyribonukleotiden zur proteinmodulation und deren verwendungen
CA3144902A1 (en) 2019-08-14 2022-01-19 Andreas Thess Rna combinations and compositions with decreased immunostimulatory properties
TW202142239A (zh) 2020-01-29 2021-11-16 美商旗艦先鋒創新有限責任公司 包含環狀多核糖核苷酸之組合物之遞送
US20230181620A1 (en) 2020-01-29 2023-06-15 Flagship Pioneering Innovations Vi, Llc Compositions for translation and methods of use thereof
EP4153224A1 (de) 2020-05-20 2023-03-29 Flagship Pioneering Innovations VI, LLC Coronavirus-antigen-zusammensetzungen und ihre verwendungen
TW202208629A (zh) 2020-05-20 2022-03-01 美商旗艦先鋒創新有限責任公司 免疫原性組成物及其用途
US20230203192A1 (en) 2020-05-20 2023-06-29 Flagship Pioneering, Inc. Compositions and methods for producing human polyclonal antibodies
MX2023002439A (es) 2020-09-03 2023-05-09 Flagship Pioneering Innovations Vi Llc Composiciones immunogénicas y usos de las mismas.
CA3193508A1 (en) 2020-09-23 2022-03-31 Myeloid Therapeutics, Inc. Improved methods and compositions for expression of nucleic acids in cells
MX2023005201A (es) 2020-11-04 2023-06-28 Myeloid Therapeutics Inc Composiciones de proteinas de fusion quimerica modificadas por ingenieria y metodos de uso de las mismas.
AU2022398478A1 (en) 2021-11-24 2024-06-13 Flagship Pioneering Innovations Vi, Llc Coronavirus immunogen compositions and their uses
CA3238735A1 (en) 2021-11-24 2023-06-01 Jennifer A. Nelson Immunogenic compositions and their uses
AU2022397292A1 (en) 2021-11-24 2024-05-30 Flagship Pioneering Innovations Vi, Llc Varicella-zoster virus immunogen compositions and their uses
TW202340460A (zh) 2021-12-17 2023-10-16 美商旗艦先鋒創新有限責任公司 用於在變性條件下富集環狀rna之方法
TW202340461A (zh) 2021-12-22 2023-10-16 美商旗艦先鋒創新有限責任公司 用於純化多核糖核苷酸之組成物和方法
TW202342064A (zh) 2021-12-23 2023-11-01 美商旗艦先鋒創新有限責任公司 編碼抗融合多肽之環狀多核糖核苷酸
WO2024097664A1 (en) 2022-10-31 2024-05-10 Flagship Pioneering Innovations Vi, Llc Compositions and methods for purifying polyribonucleotides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6486874A (en) * 1987-09-29 1989-03-31 Sanwa Kagaku Kenkyusho Co Cloned dna containing transcription promoting factor s-ii, its fragment, preparation thereof, plasmid containing said cloned dna or fragment and method for diagnosing viral disease and cancer using said cloned dna or fragment
GB8808892D0 (en) * 1988-04-15 1988-05-18 British Bio Technology Gene synthesis
US4994370A (en) * 1989-01-03 1991-02-19 The United States Of America As Represented By The Department Of Health And Human Services DNA amplification technique
US5001050A (en) * 1989-03-24 1991-03-19 Consejo Superior Investigaciones Cientificas PHφ29 DNA polymerase
US5043272A (en) * 1989-04-27 1991-08-27 Life Technologies, Incorporated Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers
US5071743A (en) * 1989-10-27 1991-12-10 Her Majesty The Queen In Right Of Canada, As Represented By The National Research Council Of Canada Process for conducting site-directed mutagenesis

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143495A (en) * 1995-11-21 2000-11-07 Yale University Unimolecular segment amplification and sequencing
US6329150B1 (en) 1995-11-21 2001-12-11 Yale University Unimolecular segment amplification and sequencing
US9487823B2 (en) 2002-12-20 2016-11-08 Qiagen Gmbh Nucleic acid amplification

Also Published As

Publication number Publication date
WO1992001813A1 (en) 1992-02-06
CA2087256A1 (en) 1992-01-26
EP0542874A4 (en) 1994-05-11
AU8417391A (en) 1992-02-18
EP0542874A1 (de) 1993-05-26
JPH06500014A (ja) 1994-01-06

Similar Documents

Publication Publication Date Title
AU649066B2 (en) Circular extension for generating multiple nucleic acid complements
EP0676476B1 (de) Isotherme Amplifikation von Nukleinsäuren durch Strangverdrängung
US5824517A (en) Method for amplifying nucleic acid sequences by strand displacement using DNA/RNA chimeric primers
JP3514630B2 (ja) 核酸配列の増幅および検出
JP3010738B2 (ja) 核酸の交雑、増幅方法
US5215899A (en) Nucleic acid amplification employing ligatable hairpin probe and transcription
JP3313358B2 (ja) 核酸の合成方法
US5869251A (en) Use of primers containing nucleotides having altered base pairing characteristics in the amplification of nucleic acid molecules
KR100231383B1 (ko) Rna 레플리카제의 dna-의존성 rna 폴리머라제 활성을 이용한 핵산 증폭
JP2807202B2 (ja) 核酸の高感度検出方法
RU2252964C2 (ru) Способ и набор для синтеза нуклеиновой кислоты, имеющей нуклеотидную последовательность, где в одной цепи попеременно связаны комплементарные нуклеотидные последовательности
WO2000056877A1 (fr) Procede d'amplification d'une sequence d'acide nucleique
US5599921A (en) Oligonucleotide families useful for producing primers
EP1280938A2 (de) Abbaubare nukleisäuresonden und detektionsverfahren für nukleisäuren
JPH02268683A (ja) 単一プライマーを用いる核酸の増幅
CA3096856A1 (en) Method for selectively adapting a polynucleotide
WO2007106802A2 (en) Method for linear amplification of bisulfite converted dna
CN113528628A (zh) 用于基因组应用和治疗应用的核酸分子的克隆复制和扩增的系统和方法
US5569582A (en) Rapid amplification and detection of nucleic acids
US20200299764A1 (en) System and method for transposase-mediated amplicon sequencing
AU724804B2 (en) Assay involving looped nucleic acid
JPH10500572A (ja) 標的核酸を検出する方法
EP0682121B1 (de) Verfahren zur ampflifizierung und zum nachweis bestimmter nukleinsäuresequenzen mittels thermostabiler enzyme
CN114364813B (zh) 多重等温扩增核酸序列的方法
WO2004053159A2 (en) Oligonucleotide guided analysis of gene expression